Jordan Gauthier, Associate Professor at Fred Hutch and the University of Washington, shared a post on X:
“Dr. Emily Liang expertly presenting at ASH25 the largest study to date diving into the use of anakinra for refractory/severe ICANS (n=101). We benchmark key clinical outcomes, and identify potential predictive biomarkers of anakinra efficacy.
Prospective comparative studies critically needed!”
More posts featuring Jordan Gauthier.